Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov “Revision” version (v3.5.3) instead of the previous one (v3.5.2), reflecting an administrative/site update rather than a change to the trial record.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision history updated: v3.5.0 was removed. v3.5.2 was added.SummaryDifference0.0%

- Check37 days agoChange DetectedHb SS disease added to related terms and Genetic and Rare Diseases Information Center added under Resources.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision tag updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded Revision: v3.4.2 and removed an outdated funding-status notice and an earlier revision note, representing site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.